By applying screening criteria of rec = 5 in the lung cancer group and rec = 9 in the nodule group, while excluding the control group, a total of 2 mutation events (ARHGAP19 and NRG1) were identified (Supplementary Figure 1B). The gene discussed is ARHGAP19; the disease is lung carcinoma.